Fulcrum Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell FULC and other ETFs, options, and stocks.About FULC
Fulcrum Therapeutics, Inc. is a clinical stage biopharmaceutical company, which develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies. Its product candidate includes Losmapimod and FTX-HbF.
CEOAlexander C. Sapir
CEOAlexander C. Sapir
Employees45
Employees45
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2015
Founded2015
Employees45
Employees45
FULC Key Statistics
Market cap355.72M
Market cap355.72M
Price-Earnings ratio-100.15
Price-Earnings ratio-100.15
Dividend yield—
Dividend yield—
Average volume1.12M
Average volume1.12M
High today$6.65
High today$6.65
Low today$5.65
Low today$5.65
Open price$5.99
Open price$5.99
Volume1.17M
Volume1.17M
52 Week high$10.13
52 Week high$10.13
52 Week low$2.32
52 Week low$2.32
Analyst ratings
43%
of 7 ratingsBuy
42.9%
Hold
42.9%
Sell
14.3%
People also own
Based on the portfolios of people who own FULC. This list is generated using Robinhood data, and it’s not a recommendation.